Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.220
+0.030 (2.52%)
At close: Dec 5, 2025, 4:00 PM EST
1.240
+0.020 (1.64%)
After-hours: Dec 5, 2025, 7:36 PM EST
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.21 million as of December 5, 2025. Its market cap has increased by 7.40% in one year.
Market Cap
2.21M
Enterprise Value
-715.65K
1-Year Change
7.40%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $2.21M, a decrease of -96.72%. That is a compound annual growth rate of -56.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 2.16M | -19.77% |
| Dec 31, 2024 | 2.69M | 78.03% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.26B |
| Johnson & Johnson | 488.36B |
| AbbVie | 403.87B |
| UnitedHealth Group | 302.33B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 251.97B |
| Abbott Laboratories | 215.94B |